Adaptimmune Therapeutics PLC (ADAP)
0.9705
+0.07
(+8.03%)
USD |
NASDAQ |
Apr 19, 16:00
0.9705
0.00 (0.00%)
After-Hours: 19:25
Adaptimmune Therapeutics Max Drawdown (5Y): 96.57% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 96.57% |
| February 29, 2024 | 96.57% |
| January 31, 2024 | 96.57% |
| December 31, 2023 | 96.57% |
| November 30, 2023 | 96.57% |
| October 31, 2023 | 96.57% |
| September 30, 2023 | 96.57% |
| August 31, 2023 | 96.57% |
| July 31, 2023 | 96.57% |
| June 30, 2023 | 96.57% |
| May 31, 2023 | 96.57% |
| April 30, 2023 | 96.57% |
| March 31, 2023 | 96.57% |
| February 28, 2023 | 96.57% |
| January 31, 2023 | 96.57% |
| December 31, 2022 | 96.57% |
| November 30, 2022 | 96.57% |
| October 31, 2022 | 96.57% |
| September 30, 2022 | 96.57% |
| August 31, 2022 | 96.57% |
| July 31, 2022 | 96.57% |
| June 30, 2022 | 96.57% |
| May 31, 2022 | 96.57% |
| April 30, 2022 | 96.57% |
| March 31, 2022 | 96.57% |
| Date | Value |
|---|---|
| February 28, 2022 | 96.57% |
| January 31, 2022 | 96.57% |
| December 31, 2021 | 96.57% |
| November 30, 2021 | 96.57% |
| October 31, 2021 | 96.57% |
| September 30, 2021 | 96.57% |
| August 31, 2021 | 96.57% |
| July 31, 2021 | 96.57% |
| June 30, 2021 | 96.57% |
| May 31, 2021 | 96.57% |
| April 30, 2021 | 96.57% |
| March 31, 2021 | 96.57% |
| February 28, 2021 | 96.57% |
| January 31, 2021 | 96.57% |
| December 31, 2020 | 96.57% |
| November 30, 2020 | 96.57% |
| October 31, 2020 | 96.57% |
| September 30, 2020 | 96.57% |
| August 31, 2020 | 96.57% |
| July 31, 2020 | 96.57% |
| June 30, 2020 | 96.57% |
| May 31, 2020 | 96.57% |
| April 30, 2020 | 96.57% |
| March 31, 2020 | 96.57% |
| February 29, 2020 | 96.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
82.81%
Minimum
Apr 2019
96.57%
Maximum
Nov 2019
95.64%
Average
96.57%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Biodexa Pharmaceuticals Plc | 100.00% |
| NuCana PLC | 98.59% |
| Autolus Therapeutics PLC | 96.58% |
| Mereo BioPharma Group PLC | -- |
| TC BioPharm (Holdings) PLC | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -51.33 |
| Beta (5Y) | 2.389 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 159.0% |
| Historical Sharpe Ratio (5Y) | -0.1267 |
| Historical Sortino (5Y) | -0.4402 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.72% |